Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aphasia, Primary Progressive | 74 | 2024 | 90 | 21.040 |
Why?
|
| Alzheimer Disease | 57 | 2025 | 515 | 10.840 |
Why?
|
| Memory, Episodic | 10 | 2024 | 60 | 4.420 |
Why?
|
| Atrophy | 35 | 2025 | 124 | 4.240 |
Why?
|
| Frontotemporal Dementia | 18 | 2024 | 30 | 4.130 |
Why?
|
| Neuropsychological Tests | 41 | 2025 | 506 | 3.730 |
Why?
|
| Cognition | 16 | 2024 | 580 | 3.630 |
Why?
|
| Aging | 16 | 2024 | 727 | 3.470 |
Why?
|
| Brain | 28 | 2024 | 2306 | 3.190 |
Why?
|
| Frontotemporal Lobar Degeneration | 15 | 2024 | 15 | 2.810 |
Why?
|
| Language | 11 | 2024 | 157 | 2.780 |
Why?
|
| Cognitive Dysfunction | 13 | 2025 | 155 | 2.770 |
Why?
|
| Aphasia | 5 | 2024 | 15 | 2.480 |
Why?
|
| Temporal Lobe | 16 | 2023 | 176 | 2.440 |
Why?
|
| Cerebral Cortex | 17 | 2025 | 591 | 2.370 |
Why?
|
| Dementia | 10 | 2025 | 203 | 2.330 |
Why?
|
| Language Tests | 15 | 2022 | 37 | 2.230 |
Why?
|
| Comprehension | 9 | 2022 | 81 | 2.100 |
Why?
|
| Neurodegenerative Diseases | 4 | 2023 | 51 | 2.030 |
Why?
|
| Aged | 80 | 2025 | 19272 | 1.790 |
Why?
|
| Humans | 138 | 2025 | 90014 | 1.510 |
Why?
|
| tau Proteins | 12 | 2023 | 77 | 1.480 |
Why?
|
| Semantics | 11 | 2022 | 48 | 1.480 |
Why?
|
| Longitudinal Studies | 22 | 2025 | 1082 | 1.380 |
Why?
|
| Aged, 80 and over | 37 | 2024 | 6787 | 1.340 |
Why?
|
| Quality of Life | 7 | 2024 | 1682 | 1.310 |
Why?
|
| Speech | 7 | 2022 | 85 | 1.240 |
Why?
|
| Middle Aged | 74 | 2025 | 26173 | 1.240 |
Why?
|
| Male | 81 | 2025 | 42705 | 1.180 |
Why?
|
| Neurofibrillary Tangles | 10 | 2022 | 46 | 1.170 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2025 | 3481 | 1.160 |
Why?
|
| Speech-Language Pathology | 2 | 2018 | 4 | 1.160 |
Why?
|
| Supranuclear Palsy, Progressive | 3 | 2023 | 22 | 1.150 |
Why?
|
| Female | 82 | 2025 | 46617 | 1.140 |
Why?
|
| Amnesia | 3 | 2021 | 15 | 1.080 |
Why?
|
| Pick Disease of the Brain | 2 | 2024 | 6 | 1.040 |
Why?
|
| Vocabulary | 5 | 2024 | 15 | 1.000 |
Why?
|
| Communication | 8 | 2024 | 461 | 1.000 |
Why?
|
| Entorhinal Cortex | 3 | 2022 | 15 | 0.980 |
Why?
|
| Positron-Emission Tomography | 9 | 2024 | 338 | 0.980 |
Why?
|
| Apolipoprotein E4 | 6 | 2023 | 27 | 0.940 |
Why?
|
| Wernicke Encephalopathy | 1 | 2023 | 6 | 0.860 |
Why?
|
| Wernicke Area | 3 | 2020 | 3 | 0.850 |
Why?
|
| Language Development Disorders | 1 | 2022 | 24 | 0.830 |
Why?
|
| DNA-Binding Proteins | 11 | 2023 | 1243 | 0.830 |
Why?
|
| Memory Disorders | 4 | 2023 | 69 | 0.830 |
Why?
|
| Amyloid beta-Peptides | 12 | 2024 | 213 | 0.820 |
Why?
|
| Communication Disorders | 1 | 2022 | 7 | 0.820 |
Why?
|
| Aphasia, Broca | 4 | 2020 | 5 | 0.800 |
Why?
|
| Age of Onset | 8 | 2025 | 318 | 0.790 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 205 | 0.780 |
Why?
|
| Language Therapy | 5 | 2023 | 5 | 0.750 |
Why?
|
| Tauopathies | 4 | 2024 | 14 | 0.730 |
Why?
|
| Apolipoproteins E | 7 | 2023 | 130 | 0.730 |
Why?
|
| Frontal Lobe | 5 | 2016 | 132 | 0.700 |
Why?
|
| Anomia | 4 | 2020 | 6 | 0.670 |
Why?
|
| Verbal Learning | 2 | 2017 | 29 | 0.670 |
Why?
|
| Healthy Aging | 2 | 2024 | 11 | 0.660 |
Why?
|
| Behavioral Symptoms | 2 | 2016 | 15 | 0.620 |
Why?
|
| Hippocampus | 2 | 2025 | 449 | 0.610 |
Why?
|
| Biomarkers | 12 | 2024 | 1778 | 0.610 |
Why?
|
| Functional Laterality | 3 | 2018 | 199 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2020 | 2360 | 0.570 |
Why?
|
| Self-Help Groups | 1 | 2017 | 14 | 0.570 |
Why?
|
| Autopsy | 7 | 2022 | 124 | 0.560 |
Why?
|
| Plaque, Amyloid | 4 | 2022 | 59 | 0.520 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 166 | 0.520 |
Why?
|
| Nerve Net | 3 | 2020 | 375 | 0.520 |
Why?
|
| Acoustic Stimulation | 3 | 2017 | 127 | 0.520 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 210 | 0.520 |
Why?
|
| Disease Progression | 7 | 2024 | 1469 | 0.510 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2015 | 17 | 0.500 |
Why?
|
| Psychological Techniques | 1 | 2015 | 3 | 0.500 |
Why?
|
| Executive Function | 5 | 2024 | 92 | 0.490 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2020 | 1255 | 0.480 |
Why?
|
| C9orf72 Protein | 7 | 2023 | 18 | 0.430 |
Why?
|
| Caregivers | 3 | 2024 | 167 | 0.410 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2024 | 125 | 0.410 |
Why?
|
| Cognitive Aging | 2 | 2022 | 8 | 0.400 |
Why?
|
| Apraxias | 2 | 2023 | 3 | 0.400 |
Why?
|
| Gyrus Cinguli | 3 | 2017 | 47 | 0.370 |
Why?
|
| Age Factors | 6 | 2021 | 1880 | 0.370 |
Why?
|
| Memory, Short-Term | 1 | 2014 | 230 | 0.360 |
Why?
|
| Microglia | 3 | 2020 | 108 | 0.350 |
Why?
|
| Amyloid | 4 | 2023 | 95 | 0.350 |
Why?
|
| Eye Movements | 3 | 2022 | 118 | 0.350 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2020 | 4 | 0.350 |
Why?
|
| Auditory Cortex | 1 | 2011 | 59 | 0.350 |
Why?
|
| Brain Mapping | 5 | 2015 | 571 | 0.350 |
Why?
|
| Neural Pathways | 5 | 2020 | 319 | 0.330 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 1863 | 0.310 |
Why?
|
| Photic Stimulation | 6 | 2019 | 502 | 0.310 |
Why?
|
| Neurons | 7 | 2022 | 1591 | 0.310 |
Why?
|
| Memory | 3 | 2021 | 220 | 0.300 |
Why?
|
| Case-Control Studies | 8 | 2020 | 1868 | 0.300 |
Why?
|
| Dyslexia | 2 | 2023 | 12 | 0.290 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2025 | 9 | 0.290 |
Why?
|
| White Matter | 3 | 2023 | 85 | 0.270 |
Why?
|
| Learning | 2 | 2023 | 286 | 0.260 |
Why?
|
| Phenotype | 5 | 2025 | 2457 | 0.250 |
Why?
|
| Aniline Compounds | 3 | 2021 | 59 | 0.250 |
Why?
|
| Language Disorders | 2 | 2017 | 9 | 0.240 |
Why?
|
| Reaction Time | 4 | 2017 | 311 | 0.230 |
Why?
|
| Psychotropic Drugs | 1 | 2024 | 79 | 0.230 |
Why?
|
| Patient Selection | 2 | 2024 | 682 | 0.230 |
Why?
|
| Speech Therapy | 2 | 2023 | 9 | 0.220 |
Why?
|
| Amyloidogenic Proteins | 4 | 2023 | 14 | 0.220 |
Why?
|
| Gliosis | 2 | 2022 | 35 | 0.220 |
Why?
|
| Dementia, Vascular | 1 | 2023 | 6 | 0.220 |
Why?
|
| United States | 6 | 2024 | 7114 | 0.220 |
Why?
|
| Behavior Therapy | 1 | 2023 | 88 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2025 | 2887 | 0.210 |
Why?
|
| Carbolines | 1 | 2022 | 8 | 0.210 |
Why?
|
| Ethylene Glycols | 2 | 2020 | 10 | 0.210 |
Why?
|
| Consensus | 1 | 2024 | 366 | 0.210 |
Why?
|
| Broca Area | 2 | 2020 | 2 | 0.200 |
Why?
|
| Goals | 1 | 2023 | 67 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2770 | 0.200 |
Why?
|
| Social Support | 2 | 2015 | 216 | 0.200 |
Why?
|
| Single-Blind Method | 1 | 2022 | 151 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 46 | 0.200 |
Why?
|
| Limbic System | 2 | 2025 | 24 | 0.190 |
Why?
|
| Linguistics | 2 | 2024 | 12 | 0.190 |
Why?
|
| Radiopharmaceuticals | 2 | 2020 | 198 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2021 | 126 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2020 | 71 | 0.180 |
Why?
|
| Prevalence | 3 | 2018 | 1250 | 0.170 |
Why?
|
| Mutation | 6 | 2023 | 4169 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2023 | 4329 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 5 | 0.170 |
Why?
|
| Adult | 10 | 2024 | 26836 | 0.170 |
Why?
|
| Rest | 1 | 2020 | 49 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 540 | 0.170 |
Why?
|
| Genetic Testing | 2 | 2023 | 543 | 0.170 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 24 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 52 | 0.160 |
Why?
|
| Parietal Lobe | 1 | 2020 | 119 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2024 | 556 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 1691 | 0.150 |
Why?
|
| Acetylcholinesterase | 1 | 2018 | 48 | 0.150 |
Why?
|
| Knowledge | 1 | 2018 | 28 | 0.150 |
Why?
|
| Neurology | 1 | 2019 | 75 | 0.150 |
Why?
|
| Verbal Behavior | 2 | 2008 | 32 | 0.150 |
Why?
|
| Retrospective Studies | 6 | 2021 | 9237 | 0.150 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 81 | 0.150 |
Why?
|
| Cognition Disorders | 2 | 2017 | 233 | 0.150 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2017 | 4 | 0.140 |
Why?
|
| Disease Management | 1 | 2019 | 327 | 0.140 |
Why?
|
| Occipital Lobe | 1 | 2016 | 24 | 0.130 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 497 | 0.130 |
Why?
|
| Dominance, Cerebral | 1 | 2016 | 66 | 0.130 |
Why?
|
| Family | 2 | 2019 | 324 | 0.130 |
Why?
|
| Aphasia, Wernicke | 1 | 2015 | 1 | 0.130 |
Why?
|
| Narration | 1 | 2015 | 17 | 0.130 |
Why?
|
| Phonetics | 2 | 2012 | 36 | 0.130 |
Why?
|
| Organ Size | 4 | 2020 | 372 | 0.120 |
Why?
|
| Autophagy | 1 | 2017 | 159 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 66 | 0.120 |
Why?
|
| Forecasting | 1 | 2016 | 304 | 0.120 |
Why?
|
| Emotional Intelligence | 1 | 2015 | 22 | 0.120 |
Why?
|
| Zebrafish | 1 | 2017 | 322 | 0.120 |
Why?
|
| Genotype | 3 | 2018 | 1852 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 365 | 0.110 |
Why?
|
| Alleles | 2 | 2017 | 1137 | 0.110 |
Why?
|
| Community Mental Health Services | 1 | 2013 | 17 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2013 | 47 | 0.110 |
Why?
|
| Interviews as Topic | 2 | 2024 | 344 | 0.110 |
Why?
|
| Qualitative Research | 2 | 2024 | 306 | 0.100 |
Why?
|
| Agraphia | 1 | 2012 | 1 | 0.100 |
Why?
|
| Odorants | 1 | 2013 | 71 | 0.100 |
Why?
|
| Word Association Tests | 1 | 2012 | 5 | 0.100 |
Why?
|
| Self Care | 1 | 2013 | 166 | 0.100 |
Why?
|
| Data Collection | 2 | 2023 | 377 | 0.100 |
Why?
|
| Pattern Recognition, Visual | 2 | 2012 | 155 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 953 | 0.090 |
Why?
|
| Reading | 2 | 2009 | 31 | 0.090 |
Why?
|
| Inclusion Bodies | 2 | 2020 | 34 | 0.090 |
Why?
|
| Speech Disorders | 1 | 2009 | 19 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2018 | 899 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2658 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2011 | 687 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 885 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 696 | 0.080 |
Why?
|
| Northwestern United States | 1 | 2008 | 7 | 0.080 |
Why?
|
| Social Behavior Disorders | 1 | 2008 | 19 | 0.070 |
Why?
|
| Medical Records | 1 | 2008 | 120 | 0.070 |
Why?
|
| Psycholinguistics | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1731 | 0.070 |
Why?
|
| Signal Detection, Psychological | 1 | 2006 | 20 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1606 | 0.070 |
Why?
|
| Nerve Degeneration | 2 | 2020 | 83 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 6418 | 0.060 |
Why?
|
| Polypharmacy | 1 | 2024 | 15 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2024 | 101 | 0.060 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2024 | 3 | 0.060 |
Why?
|
| Self-Management | 1 | 2024 | 42 | 0.060 |
Why?
|
| Presenilin-2 | 1 | 2023 | 25 | 0.060 |
Why?
|
| Neurogranin | 1 | 2023 | 3 | 0.060 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2023 | 9 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 1075 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 50 | 0.050 |
Why?
|
| Angiotensins | 1 | 2023 | 5 | 0.050 |
Why?
|
| Incidence | 1 | 2008 | 1604 | 0.050 |
Why?
|
| Perception | 1 | 2024 | 179 | 0.050 |
Why?
|
| Presenilin-1 | 1 | 2023 | 100 | 0.050 |
Why?
|
| Demography | 1 | 2024 | 183 | 0.050 |
Why?
|
| Visual Perception | 1 | 2006 | 327 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2023 | 144 | 0.050 |
Why?
|
| Dentate Gyrus | 1 | 2023 | 32 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 182 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2024 | 139 | 0.050 |
Why?
|
| RNA Interference | 1 | 2024 | 376 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2023 | 116 | 0.050 |
Why?
|
| Health Status | 1 | 2024 | 371 | 0.050 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2021 | 1 | 0.050 |
Why?
|
| Stilbenes | 1 | 2021 | 25 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 68 | 0.050 |
Why?
|
| Emotions | 1 | 2024 | 354 | 0.040 |
Why?
|
| Chicago | 1 | 2024 | 1434 | 0.040 |
Why?
|
| Gray Matter | 1 | 2020 | 35 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 11858 | 0.040 |
Why?
|
| Life Style | 1 | 2019 | 176 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 185 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 374 | 0.040 |
Why?
|
| Longevity | 1 | 2018 | 58 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2019 | 315 | 0.040 |
Why?
|
| Animals | 3 | 2024 | 27536 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 25 | 0.040 |
Why?
|
| Cell Count | 1 | 2017 | 199 | 0.040 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 373 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 646 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 108 | 0.030 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2016 | 13 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 196 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1214 | 0.030 |
Why?
|
| Attention | 1 | 2020 | 396 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 151 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 330 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 293 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cell Size | 1 | 2015 | 69 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 463 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 494 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1534 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 432 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2017 | 381 | 0.030 |
Why?
|
| Cues | 1 | 2015 | 174 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 300 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 866 | 0.030 |
Why?
|
| Olfactory Perception | 1 | 2013 | 22 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 583 | 0.030 |
Why?
|
| Heart | 1 | 2016 | 578 | 0.030 |
Why?
|
| Articulation Disorders | 1 | 2012 | 1 | 0.030 |
Why?
|
| Form Perception | 1 | 2012 | 37 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 305 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3773 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 435 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2395 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2415 | 0.020 |
Why?
|
| Child | 1 | 2018 | 7242 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2677 | 0.010 |
Why?
|